Publications

Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Zillikens D, Kerrouche N. de Berker D, Dummer R, Villemagne H

on behalf of the Excilight Study Group. A clinical study comparing Methyl Aminolevulinate Photodynamic Therapy (MAL-PDT) and Surgery in superficial Basal Cell Carcinoma, with a 12-month follow-up. J Eur Acad Dermatol Venereol (in press April 2008).

Murrell DF, Amagai M, Barnadas M, Borradori L, Bystryn JC, Cianchini G, Diaz L, Fivenson D, Goldsmith L, Hall R, Harman KE, Hashimoto T, Hertl M, Hunzelmann N, Iranzo P, Joly P, Jonkman MF, Kitajima Y, Korman N, Martin LK, Mimouni D, Pandya A, Payne A, Rubenstein D, Shimizu H, Sinha A, Sirois D, Dick S, Werth V:

Consensus statement on definitions of disease endpoints and therapeutic response for pemphigus. J Am Acad Dermatol 58 (June): 1043-6, 2008

Murrell DF, Calvieri S, Ortonne J-P, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.

A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis intolerant of, or dependent on, topical corticosteroids.. Br J Dermatol (accepted May 2007) 157:954-959, 2007. DOI 10.11 11/1.1365-2133.2007.08.192 x.

Ellis CN, Barker JN, Haig A, Parker CA, Daly S, Jayawardene DA on behalf of Avandia Study Group.

Placebo Response in Two Long-Term Randomized Psoriasis Studies that were Negative for Rosiglitazone. Am J Clin Derm 8 (2):93-102, 2007. (DM was PI for this study in Australia).

Hofman T, Cranswick N, Kuna P, Boznanski A, Latos T, Gold M, Murrell DF, et al:

Tacrolimus Ointment does not Affect the Immediate Response to Vaccination, the Generation of Immune Memory, or Humoral and Cell- Mediated Immunity in Children Arch Dis Childhood 2007 Jan;92(1):93.

Gottlieb AB, Griffiths C, Dubertret L, Ho VC, Mrowietz U, Murrell DF, Ortonne J-P, Todd G, Cherill R , Marks I, Emady-Azar S, Paul CF, for the Multi-Centre Investigator Group.

Efficacy and tolerability of oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: A double-blind, multicentre, randomized dose finding trial. Br J Dermatol 152 (June):1219-1227, 2005.

Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Reid C, Czarnecki D,  Murrell D.

Photodynamic therapy with topical methyl aminolevulinate for difficult to treat basal cell carcinoma. Br J Dermatol 152 (April):765-772, 2005.

Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson C, Weightman W, Reid C, Watson A, Foley P:

A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol Sep;43(9):687-92. 2004

Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai K-E, Murrell D, Weightman W, Anderson C, Reid C, Watson A, Foley P:

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. Jun;14(2):99-106, 2003.

Grevelink S.A., Murrell D.F. and Olsen E.A. (1992)

Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis. J Am Acad Dermatol 27:182-8.

Murrell D.F., and Olsen E.A. (1992)

Ivy Shield: a new barrier creams for the prevention of Rhus Dermatitis. In: Environmental Threat to the Skin.

Sinclair R, Cowan P, Marshman G, Howard A, Robertson I, Varigos G, Murrell D:

Efficacy and safety of once daily applications of Mometasone Furoate 0.1% (Elocon) versus twice daily applications of Methylprednisolone Aceponate 1mg/g (Advantan) for the treatment of mild-to-severe psoriasis. Cochrane Database of Unpublished Clinical Trials.